248 related articles for article (PubMed ID: 10366642)
1. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery.
Hatzidimitriou G; McCann UD; Ricaurte GA
J Neurosci; 1999 Jun; 19(12):5096-107. PubMed ID: 10366642
[TBL] [Abstract][Full Text] [Related]
2. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Fischer C; Hatzidimitriou G; Wlos J; Katz J; Ricaurte G
J Neurosci; 1995 Aug; 15(8):5476-85. PubMed ID: 7643196
[TBL] [Abstract][Full Text] [Related]
3. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.
Hatzidimitriou G; Tsai EH; McCann UD; Ricaurte GA
Synapse; 2002 Apr; 44(1):51-7. PubMed ID: 11842446
[TBL] [Abstract][Full Text] [Related]
4. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems.
Gartside SE; McQuade R; Sharp T
Neuropharmacology; 1997; 36(11-12):1697-703. PubMed ID: 9517441
[TBL] [Abstract][Full Text] [Related]
6. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine.
Callahan BT; Cord BJ; Ricaurte GA
Synapse; 2001 May; 40(2):113-21. PubMed ID: 11252022
[TBL] [Abstract][Full Text] [Related]
7. (+) 3,4-methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain.
Sexton TJ; McEvoy C; Neumaier JF
Mol Psychiatry; 1999 Nov; 4(6):572-9. PubMed ID: 10578240
[TBL] [Abstract][Full Text] [Related]
8. Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.
Gartside SE; McQuade R; Sharp T
J Pharmacol Exp Ther; 1996 Oct; 279(1):277-83. PubMed ID: 8859004
[TBL] [Abstract][Full Text] [Related]
9. Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
Ricaurte GA; McCann UD; Szabo Z; Scheffel U
Toxicol Lett; 2000 Mar; 112-113():143-6. PubMed ID: 10720723
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus.
Bonkale WL; Austin MC
Neuroscience; 2008 Jul; 155(1):270-6. PubMed ID: 18515011
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging in human MDMA (Ecstasy) users.
Cowan RL; Roberts DM; Joers JM
Ann N Y Acad Sci; 2008 Oct; 1139():291-8. PubMed ID: 18991874
[TBL] [Abstract][Full Text] [Related]
12. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.
Lew R; Sabol KE; Chou C; Vosmer GL; Richards J; Seiden LS
J Pharmacol Exp Ther; 1996 Feb; 276(2):855-65. PubMed ID: 8632359
[TBL] [Abstract][Full Text] [Related]
13. GAP-43 is critical for normal development of the serotonergic innervation in forebrain.
Donovan SL; Mamounas LA; Andrews AM; Blue ME; McCasland JS
J Neurosci; 2002 May; 22(9):3543-52. PubMed ID: 11978831
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG
Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999
[TBL] [Abstract][Full Text] [Related]
15. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.
Mamounas LA; Mullen CA; O'Hearn E; Molliver ME
J Comp Neurol; 1991 Dec; 314(3):558-86. PubMed ID: 1814975
[TBL] [Abstract][Full Text] [Related]
16. MDMA alters the response of the circadian clock to a photic and non-photic stimulus.
Colbron S; Jones M; Biello SM
Brain Res; 2002 Nov; 956(1):45-52. PubMed ID: 12426045
[TBL] [Abstract][Full Text] [Related]
17. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
Battaglia G; Sharkey J; Kuhar MJ; de Souza EB
Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of MDMA and related compounds: anatomic studies.
Molliver ME; Berger UV; Mamounas LA; Molliver DC; O'Hearn E; Wilson MA
Ann N Y Acad Sci; 1990; 600():649-61; discussion 661-4. PubMed ID: 1979216
[TBL] [Abstract][Full Text] [Related]
19. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Saadat KS; O'shea E; Colado MI; Elliott JM; Green AR
Psychopharmacology (Berl); 2005 Jun; 179(4):884-90. PubMed ID: 15650843
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
Scanzello CR; Hatzidimitriou G; Martello AL; Katz JL; Ricaurte GA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1484-91. PubMed ID: 7680719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
